Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Exercise Test × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Carcinoma, Transitional Cell 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡